Study shows that the Gam-COVID-Vac, Russia's COVID-19 vaccine, has produced an antibody response with no serious side effects in a small trial
A study shows that the Gam-COVID-Vac, Russia's COVID-19 vaccine, has produced an antibody response with no serious side effects in a small trial.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
NewsStudy shows that the Gam-COVID-Vac, Russia's COVID-19 vaccine, has produced an antibody response with no serious side effects in a small trial
View Premium plansBrowse free archive reportsA study shows that the Gam-COVID-Vac, Russia's COVID-19 vaccine, has produced an antibody response with no serious side effects in a small trial.